Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors-Reference-Cited by-全球学者库

Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors

Published:2021-05-25 Issue:6 Volume:85 Page:921-928
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsumoto Shingo¹,Kuroda Shunsuke²³,Sano Takahide¹⁴,Kitai Takeshi⁵,Yonetsu Taishi⁶,Kohsaka Shun⁷,Torii Sho⁸,Kishi Takuya⁹,Komuro Issei¹⁰,Hirata Ken-ichi¹¹,Node Koichi¹²,Matsue Yuya¹³¹⁴

Affiliation:

1. Department of Cardiovascular Medicine, Toho University Graduate School of Medicine

2. Department of Cardiology, Kameda Medical Center

3. Department of Cardiovascular Medicine, Cleveland Clinic

4. Department of Cardiology, Ebara Hospital

5. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospita

6. Department of Cardiovascular Medicine, Tokyo Medical and Dental University

7. Department of Cardiology, Keio University School of Medicine

8. Department of Cardiology, Tokai University School of Medicine

9. Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare

10. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

11. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

12. Department of Cardiovascular Medicine, Saga University

13. Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine

14. Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/85/6/85_CJ-21-0160/_pdf

Reference29 articles.

1. 1. World Health Organization (WHO). WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/ (accessed December 1, 2020).

2. 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242.

3. 3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.

4. 4. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–2059.

5. 5. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999; 99: 1165–1172.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic – Observational cohort study using Japanese administrative data;Journal of Cardiology;2024-02

2. Role of precision medicine in obstructive sleep apnoea;BMJ Medicine;2023-01

3. Second Nationwide Survey of Japanese Cardiac Rehabilitation Training Facilities During the Coronavirus Disease 2019 (COVID-19) Outbreak;Circulation Reports;2022-10-07

4. Full and simplified assessment of left ventricular diastolic function in covid‐19 patients admitted to ICU: Feasibility, incidence, and association with mortality;Echocardiography;2022-10-06

5. Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors;Scientific Reports;2022-08-10